N-acetyl cysteine therapy does not prevent renal failure in high-risk patients undergoing open-heart surgery

Heart Surgery Forum

Volumn 19, Issue 1, 2016, Pages E16-E22

  Rababa'h, Abeer M ^a   Deo, Salil V ^b   Altarabsheh, Salah E ^c   De Caro, Jessica ^b   Tarboush, Nafez Abu ^d   Alzoubi, Karem H ^a   Ababneh, Mera ^a   McConnell, Bradley K ^e   Markowitz, Alan H ^b   Park, Soon J ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c King Hussein Medical Center Queen Alia Heart institute   (Jordan)

^d UNIVERSITY OF JORDAN   (Jordan)

^e UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; PLACEBO; SCAVENGER; URINARY TRACT AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR MORTALITY; CREATININE BLOOD LEVEL; DISEASE DURATION; HEMODIALYSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; META ANALYSIS; OPEN HEART SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ACUTE KIDNEY INJURY; AGED; FEMALE; HEART SURGERY; HOSPITAL MORTALITY; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; UTILIZATION;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; FREE RADICAL SCAVENGERS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL AGENTS; RISK FACTORS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84959905620     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/hsf.1424     Document Type: Article

References (20)

1. Adabag AS, Ishani A, Koneswaran S, et al. 2008. Utility of N-Acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J 155:1143-9.
2. Adabag AS, Ishani A, Bloomfield HE, Ngo AK, Wilt TJ. 2009. Efficacy of N-Acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J 30:1910-17.
3. Barr LF, Kolodner K. 2008. N-Acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med. 36:1427-35.
4. Burns KE, Chu MW, Novick RJ, et al. 2005. Perioperative N-Acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 294:342-50.
5. El-Hamamsy I, Stevens LM, Carrier M, et al. 2007. Effect of intravenous N-Acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 133:7-12.
6. Fischer UM, Tossios P, Mehlhorn U. 2005. Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opinion 21:1161-4.
7. Haase M, Haase-Fielitz A, Bagshaw SM, et al. 2007. Phase II, randomized, controlled trial of high-dose N-Acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 35:1324-31.
8. Ho KM, Morgan DJ. 2009. Meta-Analysis of N-Acetylcysteine to prevent acute renal failure after major surgery. Am J Kid Dis 53:33-40.
9. Liberati A, Altman DG, Tetzlaff J, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1-34.
10. Mehta RL, Kellum JA, Shah SV, et al. 2007. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.
11. Orhan G, Yapici N, Yuksel M, et al. 2006. Effects of N-Acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart and Vessels 21:42-7.
12. Prasad A, Banakal S, Muralidhar K. 2010. N-Acetylcysteine does not prevent renal dysfunction after off-pump coronary artery bypass surgery. European journal of anaesthesiology. 27:973-7.
13. Ristikankare A, Kuitunen T, Kuitunen A, et al. 2006. Lack of renoprotective effect of i.v. N-Acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Brit J Anaesth 97:611-16.
14. Santana-Santos E, Gowdak LH, Gaiotto FA, et al. 2014. High dose of N-Acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization. Ann Thorac Surg 97:1617-23.
15. Sisillo E, Ceriani R, Bortone F, et al. 2008. N-Acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 36:81-6.
16. Song JW, Shim JK, Soh S, Jang J, Kwak YL. 2015. Double-blinded, randomised controlled trial of N-Acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology 20:96-102.
17. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. 2000. Prevention of radiographic-contrast-Agent-induced reductions in renal function by acetylcysteine. New Engl J Med 343:180-4.
18. van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review G. 2003. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 28:1290-9.
19. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. 2007. N-Acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. J Can D'anesth 54:872-81.
20. Zhu J, Yin R, Shao H, Dong G, Luo L, Jing H. 2007. N-Acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg 133:696-703.